Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001209191-20-033404

Chairman and CEO bought 5,700 shares at an average $1.55 ($8,832)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Niihara Yutaka Chairman and CEO 2020-05-29 Purchase +3,200 $1.51 $4,832 10,642,993 D
Niihara Yutaka Chairman and CEO 2020-06-01 Purchase +2,500 $1.60 $4,000 10,645,493 D
Open-market purchases · 5,700 sh · avg $1.55 · $8,832
Loading xslF345X03/doc4.xml…